Safety of long-acting β-agonists: urgent need to clear the air remains

被引：41

作者：

Beasley, R. ^{[1
]}

Martinez, F. D. ^{[2
]}

Hackshaw, A. ^{[3
]}

Rabe, K. F. ^{[5
]}

Sterk, P. J. ^{[6
]}

Djukanovic, R. ^{[4
]}

机构：

[1] Med Res Inst New Zealand, Wellington, New Zealand

[2] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA

[3] UCL, Canc Trials Ctr, London WC1E 6BT, England

[4] Univ Southampton, Div Infect Inflammat & Repair, Southampton, Hants, England

[5] Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands

[6] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1105 AZ Amsterdam, Netherlands

来源：

EUROPEAN RESPIRATORY JOURNAL | 2009年 / 33卷 / 01期

关键词：

BRONCHODILATOR SUBSENSITIVITY; ASTHMA; SALMETEROL; SALBUTAMOL; FORMOTEROL; DEATHS; RISK;

D O I：

10.1183/09031936.00163408

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：3 / 5

页数：3

共 26 条

[1] Bronchodilator treatment and deaths from asthma: case-control study [J].

Anderson, HR ;

Ayres, JG ;

Sturdy, PM ;

Bland, JM ;

Butland, BK ;

Peckitt, C ;

Taylor, JC ;

Victor, CR .

BRITISH MEDICAL JOURNAL, 2005, 330 (7483) :117-120

[2]

ARVIDSSON P, 1991, EUR RESPIR J, V4, P1168

[3] Global strategy for asthma management and prevention: GINA executive summary [J].

Bateman, E. D. ;

Hurd, S. S. ;

Barnes, P. J. ;

Bousquet, J. ;

Drazen, J. M. ;

FitzGerald, M. ;

Gibson, P. ;

Ohta, K. ;

O'Byrne, P. ;

Pedersen, S. E. ;

Pizzichini, E. ;

Sullivan, S. D. ;

Wenzel, S. E. ;

Zar, H. J. .

EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (01) :143-178

[4] SEREVENT NATIONWIDE SURVEILLANCE STUDY - COMPARISON OF SALMETEROL WITH SALBUTAMOL IN ASTHMATIC-PATIENTS WHO REQUIRE REGULAR BRONCHODILATOR TREATMENT [J].

CASTLE, W ;

FULLER, R ;

HALL, J ;

PALMER, J .

BRITISH MEDICAL JOURNAL, 1993, 306 (6884) :1034-1037

[5] LONG-TERM EFFECTS OF A LONG-ACTING BETA-2-ADRENOCEPTOR AGONIST, SALMETEROL, ON AIRWAY HYPERRESPONSIVENESS IN PATIENTS WITH MILD ASTHMA [J].

CHEUNG, D ;

TIMMERS, MC ;

ZWINDERMAN, AH ;

BEL, EH ;

DIJKMAN, JH ;

STERK, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (17) :1198-1203

[6] MARKERS OF RISK OF ASTHMA DEATH OR READMISSION IN THE 12 MONTHS FOLLOWING A HOSPITAL ADMISSION FOR ASTHMA [J].

CRANE, J ;

PEARCE, N ;

BURGESS, C ;

WOODMAN, K ;

ROBSON, B ;

BEASLEY, R .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1992, 21 (04) :737-744

[7] Ecologic analysis of asthma-related events and dispensing of inhaled corticosteroid- and salmeterol-containing products [J].

DiSantostefano, Rachael L. ;

Davis, Kourtney J. ;

Yancey, Steve ;

Crim, Courtney .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (06) :558-565

[8]

*FDA CTR DRUG EV R, 2005, SUMM MIN PULM ALL DR

[9]

Global Initiative for Asthma, GLOB STRAT ASTHM MAN

[10]

Greenstone IR, 2005, Cochrane Database Syst Rev., V4, DOI DOI 10.1002/14651858

← 1 2 3 →